Mar 17, 2020
Compugen Announces Closing of $75 Million Public Offering of Ordinary Shares
Mar 16, 2020
Tiziana Announces Closing of Offering and Resulting Total Voting Rights
Mar 12, 2020
TriMas Announces Increased Share Repurchase Authorization to $250 Million
Mar 12, 2020
Compugen Announces Pricing of $75 Million Public Offering of Ordinary Shares
Mar 11, 2020
Commission-free trading is now available on TradeUP's newly launched web platform
Mar 11, 2020
Neonode Reports Year Ended December 31, 2019 Financial Results
Mar 11, 2020
Compugen Announces Commencement of Public Offering of Ordinary Shares
Mar 11, 2020
Tiziana Announces Pricing of U.S. Follow-On Offering of ADSs Raising $10 Million
Mar 03, 2020
TriMas Closes on Acquisition of RSA Engineered Products
Mar 02, 2020
Protagonist Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results
Mar 02, 2020
Protagonist Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results
Mar 02, 2020
Protagonist Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results
Mar 02, 2020
Protagonist Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results
Feb 28, 2020
New Research Uncovers the Toll Rare Diseases Take on Relationships
Feb 25, 2020
Origin Agritech to File Form 20-F As Soon As Possible
Feb 24, 2020
Applied DNA Announces Receipt of International Patents on its Beacon® Secure Optical Molecular Marker Technologies
Feb 24, 2020
Securities and Exchange Commission (SEC) Order for Halt in trading of Aethlon Medical Stock Expires
Feb 21, 2020
TriMas Announces Key Addition to Rapak and Packaging Group
Feb 20, 2020
TriMas Announces Agreement to Acquire Rapak
Feb 19, 2020
NeuroVive Pharmaceutical AB Year End Report January - December 2019